powered by MultiView

Pharmaceutical Exclusives

Telemedicine: Gains, losses, and debates

Telemedicine: Gains, losses, and debates

Wednesday, September 23, 2020

Telemedicine and telehealth are apparently here to stay, galvanized into intensive service amidst the COVID-19 pandemic. With approximately 20% of all medical visits in the United States estimated to be conducted via telemedicine during the course…

Trending in Pharmaceutical
Recent Articles